SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPod Point Regulatory News (PODP)

  • There is currently no data for PODP

New Contract Win

25 Nov 2021 16:13

RNS Number : 6462T
Pod Point Group Holdings PLC
25 November 2021
 

25 November 2021

 

 

Pod Point Group Holdings plc

(the "Company" or "Pod Point")

 

New contract win

 

Pod Point, one of the UK's market leading providers of Electric Vehicle ("EV") charging solutions, is pleased to announce that it has signed a partnership with German luxury car manufacturer, Mercedes-Benz.

 

Under the terms of the contract, which will run for two years, Pod Point will become a Mercedes-Benz preferred supplier of domestic charge points, on a referral basis, to its UK customers at the time of their EV purchase .

 

 

Erik Fairbairn, Chief Executive Officer of Pod Point, said: "We're thrilled to be working with Mercedes-Benz as a preferred charge point supplier. As well as allowing for a more sustainable future, EVs are opening up new avenues for bolder and more progressive designs and we're excited about the electrified vehicles Mercedes-Benz will bring to market in the coming months. This underpins our confidence in our longer term growth ambitions."

 

Enquiries

Tulchan Communications(Public relations advisor to Pod Point)

+44 207 353 4200

PodPoint@tulchangroup.com

James Macey White, Mark Burgess, Matt Low, Laura Marshall, Arthur Rogers

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTBLBDBBBDDGBU
Date   Source Headline
3rd Apr 20247:00 amRNSChange of Joint Corporate Broker
3rd Apr 20247:00 amRNSNotice of Results
2nd Apr 20249:00 amRNSEstablishment of Technology Committee
12th Mar 20249:00 amRNSChange of Registered Office
29th Feb 20248:33 amRNSTotal Voting Rights
20th Feb 20247:00 amRNSCEO Appointment & Directorate Change
20th Feb 20247:00 amRNSTrading Update
14th Feb 202411:24 amRNSBlock Listing Application
31st Jan 202410:45 amRNSTotal Voting Rights
10th Jan 202410:07 amRNSDirector Declaration
8th Dec 20238:47 amRNSBlock listing Interim Review
20th Nov 20233:13 pmRNSDirector/PDMR Shareholding
16th Nov 20237:00 amRNSTrading Update and Capital Markets Day
17th Aug 20232:29 pmRNSNotice of Capital Markets Day
10th Aug 20239:00 amRNSNew Contract Win
31st Jul 20237:00 amRNSHalf-year Report
28th Jul 20239:00 amRNSChange of Auditor
27th Jul 20234:11 pmRNSUpdated 2023 Guidance
6th Jul 20237:00 amRNSDirectorate Change
30th Jun 20239:00 amRNSNew Contract Win
28th Jun 20239:00 amRNSNew Contract Win
14th Jun 202310:10 amRNSResult of AGM
8th Jun 20239:14 amRNSBlock listing Interim Review
31st May 20239:29 amRNSDirector Declaration
25th May 20231:50 pmRNSDirector/PDMR Shareholding
28th Apr 20235:27 pmRNSAnnual Report & Notice of AGM
31st Mar 20233:47 pmRNSDirector/PDMR Shareholding
31st Mar 202310:24 amRNSTotal Voting Rights
21st Mar 20234:35 pmRNSPrice Monitoring Extension
16th Mar 20234:35 pmRNSPrice Monitoring Extension
15th Mar 20234:35 pmRNSPrice Monitoring Extension
13th Mar 20234:35 pmRNSPrice Monitoring Extension
9th Mar 20231:37 pmRNSBlock Listing Application
17th Feb 20237:00 amRNSPreliminary Unaudited Results for FY2022
16th Feb 20239:58 amRNSBoard Committee Change
11th Jan 20237:00 amRNSCompany Secretary Change
3rd Jan 20237:00 amRNSTotal Voting Rights
28th Dec 202210:32 amRNSDirector/PDMR Shareholding
22nd Dec 20224:41 pmRNSSecond Price Monitoring Extn
22nd Dec 20224:35 pmRNSPrice Monitoring Extension
14th Dec 20227:00 amRNSExercise of Options and Issue of Shares
9th Dec 20227:00 amRNSBlock listing Interim Review
5th Dec 20227:00 amRNSCFO Appointment
21st Nov 20227:00 amRNSTrading Statement
7th Nov 20224:40 pmRNSSecond Price Monitoring Extn
7th Nov 20224:35 pmRNSPrice Monitoring Extension
31st Oct 20224:35 pmRNSPrice Monitoring Extension
18th Oct 20224:36 pmRNSPrice Monitoring Extension
3rd Oct 20227:00 amRNSTotal Voting Rights
27th Sep 20224:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.